To examine the role of IL-17A/IL-17R in controlling cancer cell proliferation, we selected two well-characterized tumor cell lines, B16 melanoma and 4T1 mammary carcinoma, for our study and created IL-17RCKD clones using retroviral shRNA constructs alone with pSMP control vector. Here, IL17RA is linked to neoplasm.